| EX1164 IMMUNOHISTOCHEMISTRY: DIGITAL BREAST CANCER PANEL 3 |
| Specimen: |
Submit Tissue in 10% formal-saline OR formalin-fixed paraffin-embedded Tissue Block. Ship at room temperature. |
| Stability: |
| Room |
Refrigerated |
Frozen |
| NA |
NA |
NA |
|
| Method: |
Light Microscopy, IHC, Digital Photography |
| Comment: |
Photographs with AI read-out will be provided. Samples received on holidays will be reported in the next schedule / next working day. |
| Report: |
Contact us to know the TAT. |
| Usage: |
ER & PR receptor assays are routinely performed on Breast carcinomas to assess responsiveness to endocrine therapy and prognosis. The her-2 expression shows responsiveness to Herceptin therapy. Reporting through digital images using Visiopharm AI algorithms enhances the sensitivity of the assay. |
| Doctor Specialty: |
Oncologist |
| Disease: |
Cancer |
| Components: |
*ER *PR *HER-2 *Photomicrograph *Includes Pathologist review for presence of malignant cells |
| Courier Charges: |
|
| Home Collection: |
Available (*T&C Apply) |
| Department: |
Histopathology |
| Pre Test Information: |
Provide a copy of the Histopathology report, Site of biopsy, and Clinical history. |
Reviews
There are no reviews yet.